Author: Hindawi, Salwa I.; Hashem, Anwar M.; Damanhouri, Ghazi A.; Elâ€Kafrawy, Sherif A.; Tolah, Ahmed M.; Hassan, Ahmed M.; Azhar , Esam I.
Title: Inactivation of Middle East respiratory syndromeâ€coronavirus in human plasma using amotosalen and ultraviolet A light Cord-id: w1quh4fx Document date: 2017_12_14
ID: w1quh4fx
Snippet: BACKGROUND: Middle East respiratory syndromeâ€coronavirus (MERSâ€CoV) is a novel zoonotic pathogen. Although the potential for MERSâ€CoV transmission through blood transfusion is not clear, MERSâ€CoV was recognized as a pathogen of concern for the safety of the blood supply especially after its detection in whole blood, serum, and plasma of infected individuals. Here we investigated the efficacy of amotosalen and ultraviolet A light (UVA) to inactivate MERSâ€CoV in freshâ€frozen plasma (FF
Document: BACKGROUND: Middle East respiratory syndromeâ€coronavirus (MERSâ€CoV) is a novel zoonotic pathogen. Although the potential for MERSâ€CoV transmission through blood transfusion is not clear, MERSâ€CoV was recognized as a pathogen of concern for the safety of the blood supply especially after its detection in whole blood, serum, and plasma of infected individuals. Here we investigated the efficacy of amotosalen and ultraviolet A light (UVA) to inactivate MERSâ€CoV in freshâ€frozen plasma (FFP). STUDY DESIGN AND METHODS: Pooled FFP units were spiked with a recent clinical MERSâ€CoV isolate. Infectious and genomic viral titers were determined in plasma before and after inactivation with amotosalen/UVA treatment by plaque assay and reverse transcription–quantitative polymerase chain reaction, respectively. In addition, residual replicating or live virus after inactivation was examined by passaging in the permissive Vero E6 cells. RESULTS: The mean MERSâ€CoV infectious titer in pretreatment samples was 4.67 ± 0.25 log plaqueâ€forming units (pfu)/mL, which was reduced to undetectable levels after inactivation with amotosalen/UVA demonstrating a mean log reduction of more than 4.67 ± 0.25 pfu/mL. Furthermore, inoculation of inactivated plasma on Vero E6 cells did not result in any cytopathic effect (CPE) even after 7 days of incubation and three consecutive passages, nor the detection of MERS RNA compared to pretreatment samples which showed complete CPE within 2 to 3 days postinoculation and log viral RNA titer ranging from 9.48 to 10.22 copies/mL in all three passages. CONCLUSION: Our data show that amotosalen/UVA treatment is a potent and effective way to inactivate MERSâ€CoV infectious particles in FFP to undetectable levels and to minimize the risk of any possible transfusionâ€related MERSâ€CoV transmission.
Search related documents:
Co phrase search for related documents- abdulaziz university and acute respiratory syndrome sars cov coronavirus: 1, 2, 3, 4, 5
- acid testing and acute patient: 1, 2, 3, 4, 5
- acid testing and acute respiratory syndrome sars cov coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acid testing and live virus: 1
- acute respiratory syndrome sars cov coronavirus and address difficult: 1, 2
- acute respiratory syndrome sars cov coronavirus and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- additional screening assay and live virus: 1
- address difficult and live virus: 1, 2
Co phrase search for related documents, hyperlinks ordered by date